BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30405838)

  • 1. The prognostic value of long noncoding RNA ZEB1-AS1 on clinical outcomes in human cancer.
    Wu Y; Ding M; Wei S; Wu T; Xu R; Zhu X; Liu H
    J Cancer; 2018; 9(20):3690-3698. PubMed ID: 30405838
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: A meta-analysis.
    Liang C; Liu J; Ge H; Xu Y; Li G; Wu J
    Clin Chim Acta; 2018 Sep; 484():91-98. PubMed ID: 29778540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of long non-coding RNA ZEB1-AS1 as a prognostic biomarker in human solid tumors: A meta-analysis.
    Zuo XL; Cai J; Chen ZQ; Zhang Y; Liang LH; Wang JF; Wang JG; Wu J; Mao JD
    Clin Chim Acta; 2018 Oct; 485():14-20. PubMed ID: 29906419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significant prognostic value of ZEB1-AS1 up-regulation in patients with cancer.
    Ni Y; Fang J; Zhu L; Jiang H; Liu Y; Miao R; Shao C; Shao S
    J Cancer; 2018; 9(14):2502-2509. PubMed ID: 30026848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA ZEB1-AS1 expression in cancer prognosis: Review and meta-analysis.
    Chen C; Feng Y; Wang X
    Clin Chim Acta; 2018 Sep; 484():265-271. PubMed ID: 29885321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of long non-coding RNA ZEB1-AS1 in Chinese cancer patients: A Meta-analysis.
    Zhou X; Fan YH; Wang Y; Wang F; Liu Y
    Medicine (Baltimore); 2019 Apr; 98(17):e15251. PubMed ID: 31027073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
    Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
    BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of long noncoding RNA ZEB1 anti-sense1 in cancer patients: A meta-analysis.
    Cheng S; Guo S; He H; Kaminga AC; Xu H
    Medicine (Baltimore); 2020 Jul; 99(31):e21307. PubMed ID: 32756112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
    Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
    Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers: A systematic review and meta-analysis.
    Zhou X; Fan YH; Wang Y; Liu Y
    Medicine (Baltimore); 2019 Dec; 98(49):e18264. PubMed ID: 31804362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.
    Zhang C; Ren X; Liu Z; Tu C
    BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of the prognostic value of long non-coding RNA AFAP1-AS1 for cancer patients in China.
    Liu RH; Wang MY; Chen LY; Yin ZJ; Ji QK; Wang YY; Jin BZ
    Oncotarget; 2018 Jan; 9(8):8100-8110. PubMed ID: 29487718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical prognostic value of long noncoding RNA HAND2-AS1 in cancer patients: A study based on meta-analysis and TCGA data (PRISMA).
    Yan Z; Lu J; Xu X; You Y; Xu J; Xu T
    Medicine (Baltimore); 2022 Sep; 101(39):e30789. PubMed ID: 36181101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
    Zhong P; Hua H; Chen S; Zhu Z; Xie F
    Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.
    Shu Q; Liu X; Yang J; Mou T; Xie F
    Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and Clinicopathological Significance of Long Non-Coding RNA BLACAT1 in Cancer: An Updated Meta-Analysis and TCGA Data Review.
    Wu T; Wang Q; Ding M; Zhu X; Wu Y
    Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of lncRNA ZEB1-AS1 in non-small cell lung cancer is associated with poor prognosis.
    Xie J; Wu Y; Bian X; Chen D; Gui Q; Huang J
    Int J Clin Exp Pathol; 2018; 11(7):3703-3707. PubMed ID: 31949753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinicopathologic significance of long non-coding RNA opa-interacting protein 5-antisense RNA 1 in multiple human cancers.
    Ren X; He J; Qi L; Li S; Zhang C; Duan Z; Wang W; Tu C; Li Z
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):353-361. PubMed ID: 31899963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.